Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 3Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Leukemia 6Recurrence 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma 4Lymphoma, Extranodal NK-T-Cell 3Lymphoma, Non-Hodgkin 2Leukemia, Myeloid, Acute 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Neoplasms 1Multiple Myeloma 1Lymphoma, T-Cell 1Leukemia, T-Cell 1Leukemia, Biphenotypic, Acute 1Leukemia, B-Cell 1Hodgkin Disease 1Burkitt Lymphoma 1

Interventions

pegaspargase 1nilotinib 1merphos 1dexamethasone acetate 1dexamethasone 21-phosphate 1Vorinostat 1Vincristine 1Mitoxantrone 1Methotrexate 1Dexamethasone 1Decitabine 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Precursor B-Cell Lymphoblastic Leukemia-Lymphoma × pegaspargase × Clear all
NCT01483690 2020-10-27

A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1/2 Terminated
23 enrolled 13 charts
LymphoidOther hematologic neoplasm

Leukemia, Recurrence, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡